LIMA1 and cancer: Interestingly, depleted or mutant EPLIN impacts the interactions with NPC1L1 to weaken cholesterol absorption in intestines, potentially decreasing the risk of high LDL-C-related diseases, which provides a different picture of this tumour suppressor, as its downregulation in cancer cells often leads to promotion of cancer developments.